https://www.gosh.nhs.uk/our-research/our-research-infrastructure/nihr-great-ormond-street-hospital-brc/brc-news/gosh-brc-team-define-new-autoinflammatory-disease-caused-mutation-wdr1/
GOSH BRC team define a new autoinflammatory disease caused by a mutation in WDR1
30 Mar 2017, 11:24 a.m.
Research carried out by BRC-funded Professor Paul Brogan and his team has defined a new autoinflammatory disease (AID) in humans with periodic fevers, immunodeficiency and intermittent thrombocytopenia.
AIDs are a group of diseases that cause systemic inflammation caused by abnormalities in the innate immune system. Recently a new AID, which is caused by a recessive mutation in the WDR1 gene, has been described in an animal model. This study identified a family with severe AID displaying similar features to those displayed in the WDR1 deficient mice.
The two patients described, exhibited severe oral inflammation with scars, periodic fevers with immunodeficiency and thrombocytopenia (low blood platelet count) and findings revealed both patients to have a homozygous missense mutation in WDR1, resembling that exhibited in the WDR1 mutated mice. These findings extend the findings from the animal model and highlight the importance of WDR1 in the activation of the inflammasome and in human autoinflammation.
These findings have been published in The Journal of Experimental Medicine.
![](https://media.gosh.nhs.uk/images/2025_RDD_-_GOSH_Website_Banner_1825_x_855_px.width-765.jpg)
Join us in the countdown to Rare Disease Day 2025
Rare Disease Day takes place annually on the last day of February and is a global opportunity to increase awareness and advocate for those living with rare conditions.
![](https://media.gosh.nhs.uk/images/lab_test_tubes.width-765.jpg)
Twelve days of Research and Innovation at GOSH
It’s been a busy year for Research and Innovation at GOSH, with a number of ground breaking research trials, advanced data projects and technology pilots. To round off the year, here are just twelve of the stories (and amazing staff and researchers) that
![](https://media.gosh.nhs.uk/images/Eddie_ZVv9yai.width-765.jpg)
World-first genomic testing scheme ensures every child gets the best cancer treatment for them
Children with cancer are being offered treatment plans tailored to their specific cancer thanks to a single genomic test that reads more than three billion letters of DNA to identify cancer-causing mutations.
![](https://media.gosh.nhs.uk/images/louis-reed-pwcKF7L4-no-unsplash.original.width-765.jpg)
Global genomic collaboration improves lives and treatment for children with epilepsy
An international research collaboration, including GOSH and our research partner UCL Institute of Child Health, has shown that a technique known as rapid genome sequencing can provide a diagnosis for 43 per cent of children with unexplained epilepsy.